BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1373425)

  • 1. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved fusion partners transfected with DNA fragment encoding IL-11 on generation of human B lymphocyte hybridomas.
    Zhu Y; Jin B; Jiang S; Sun K; Sun C; Liu X
    Hum Antibodies; 1999; 9(1):1-7. PubMed ID: 10331181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased proportion of B cell hybridomas secreting monoclonal antibodies of desired specificity in cultures containing macrophage-derived hybridoma growth factor (IL-6).
    Bazin R; Lemieux R
    J Immunol Methods; 1989 Jan; 116(2):245-9. PubMed ID: 2783446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mouse-human hybridoma as a useful fusion partner for the establishment of mouse-human-human hybridoma secreting anti-tetanus toxoid human monoclonal antibody of IgM or IgG class.
    Hirata Y; Sugawara I
    Microbiol Immunol; 1987; 31(3):231-45. PubMed ID: 3613992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
    Gustafsson B; Jondal M; Sundqvist VA
    Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells.
    Takahashi M; Fuller SA; Hurrell JG
    J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell biology of human IgM-producing hybridomas derived from a fusion of human spleen lymphocytes with mouse myeloma cells.
    Jahn S; Grunow R; Kiessig ST; Bogacheva GT; Arsenjeva EL; Hlinak A; Rocklin OV; von Baehr R
    Hybridoma; 1987 Dec; 6(6):679-87. PubMed ID: 3436627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in the basic technology of electrofusion for generation of antibody-producing hybridomas.
    Ohnishi K; Chiba J; Goto Y; Tokunaga T
    J Immunol Methods; 1987 Jun; 100(1-2):181-9. PubMed ID: 3110294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved fusion technique. II. Stability and purity of hybrid clones.
    Westerwoudt RJ; Naipal AM; Harrisson CM
    J Immunol Methods; 1984 Mar; 68(1-2):89-101. PubMed ID: 6538588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short-duration polyethylene glycol fusion technique for increasing production of monoclonal antibody-secreting hybridomas.
    Lane RD
    J Immunol Methods; 1985 Aug; 81(2):223-8. PubMed ID: 4020150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential generation of monoclonal IgG-producing hybridomas by use of vesicular stomatitis virus-mediated cell fusion.
    Nagata S; Yamamoto K; Ueno Y; Kurata T; Chiba J
    Hybridoma; 1991 Jun; 10(3):369-78. PubMed ID: 1655635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human interleukin-6 enhances the immunoglobulin secretion of a rabbit-rabbit hybridoma.
    Liguori MJ; Hoff-Velk JA; Ostrow DH
    Hybridoma; 2001 Jun; 20(3):189-98. PubMed ID: 11461668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased yields of IgG2a- and IgG3-secreting hybridomas after fusion of B cells from mice with autoimmune diseases.
    Yin BW; Wong GY; Lloyd KO; Oettgen HF; Welt S
    J Immunol Methods; 1991 Nov; 144(2):165-73. PubMed ID: 1960413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive loss of human DNA accompanies loss of antibody production in heteromyeloma hybridoma cells.
    Koropatnick J; Pearson J; Harris JF
    Mol Biol Med; 1988 Apr; 5(2):69-83. PubMed ID: 3260988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of murine monoclonal antibodies in serum-free medium.
    Liu RS; Ta D; Payne J; Coccia M; Kuus-Reichel K
    Hybridoma; 1998 Feb; 17(1):69-72. PubMed ID: 9523240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
    Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
    J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitated cell fusion for hybridoma production.
    Conrad MK; Lo MM
    Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.